Unlock better outcomes with real-world closed claims data from taXonomy
As high-value therapies become the new norm,life sciences teams need closed claims data that...
As high-value therapies become the new norm,life sciences teams need closed claims data that...
In atopic dermatitis, 23% of new patient starts come from HCPs that brand teams either deprioritize or don’t have in their data at all. One in three top-decile prescribers in that same market saw zero new patient starts over a 22-month stretch. In ob...